Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03364153
Recruitment Status : Active, not recruiting
First Posted : December 6, 2017
Last Update Posted : March 4, 2019
Sponsor:
Information provided by (Responsible Party):
Ophthotech Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : September 2020
  Estimated Study Completion Date : September 2020